This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Gary C. Brown, MD; Melissa M. Brown, MN; George L. Spaeth, MD
Philadelphia

Arch Ophthalmol. 1986;104(3):336-337.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—We read with great interest the article by Fraunfelder and Meyer in a recent issue of the American Journal of Ophthalmology.¹ The cases accumulated by the authors, although anecdotal, suggest that deleterious cardiovascular effects may occur secondary to topical application of 2.5% phenylephrine hydrochloride solution. This work is further supported by the data of Kumar and associates² who demonstrated a mild rise in mean blood pressure in combination with plasma measurements of phenylephrine among patients undergoing general anesthesia. Within this latter series, the drops were administered after the induction of anesthesia and, presumably, with the patient in a supine position. In these instances, it would be expected that the eyedrops would pool within the palpebral fissures, rather than having the excess roll down the face, as usually occurs when a sitting patient receives topical eyedrops.

Topical phenylephrine in a 2.5% solution is a widely . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?